NTRA

#434
Natera, Inc. - Common Stock
220.8 7 USD
+3.14%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
211.40
221.50
Rango anual
131.81
256.27
Cambio diario
+3.14%
Variación mensual
+11.90%
Variación en los últimos 6 meses
-7.44%
Cambio anual
+40.23%
Cierres anteriores
214.1 4
Open
214.9 7
Mínimo
211.4 0
High
221.5 0
Volumen
638
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 31.63 B
  • Employee 6 140
  • Founded 2004
  • CEO Steven Chapman
  • Website www.natera.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1BQ86
  • Industry Diagnóstico y pruebas
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-150.72
Relación precio/flujo de caja
13.58

Natera, Inc. - Common Stock

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas.

Noticias